Use of circulating tumour DNA to prospectively guide a switch from targeted to immune therapy in BRAF mutant advanced melanoma: the randomised phase II CAcTUS trial DOI: 10.1038/s41467-026-72735-8
Cell-free DNA methylome and fragmentome analysis for relapse monitoring of Ewing sarcoma DOI: 10.1038/s44321-026-00396-7
Preanalytical variables and analytes in liquid biopsy approach for brain tumors: A comprehensive review and recommendations from the RANO Group and the Brain Liquid Biopsy Consortium DOI: 10.1093/neuonc/noaf140
Nanopore-based consensus sequencing enables accurate multimodal tumor cell-free DNA profiling DOI: 10.1101/gr.279144.124
Cell-free and extrachromosomal DNA profiling of small cell lung cancer DOI: 10.1016/j.molmed.2024.08.004
The effects of bioinformatics preprocessing on cell-free DNA fragment analysis DOI: 10.1093/gigascience/giaf139
Pelvis Or Involved Node Treatment: Eradicating Recurrence in Prostate Cancer (POINTER-PC) – study protocol paper for a phase III multicentre, open-label randomised controlled trial DOI: 10.1136/bmjopen-2024-095560
